Allergy and Immunology, Allergy · Watertown, NY
NPI
1922100247
Since 2006
Specialty
Allergy and Immunology, Allergy
Code 207KA0200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
19316 US Route 11, Building IV, Suite C
Watertown, NY, 13601
Phone (315) 681-4192
Groups this clinician bills Medicare through
Medicare paid, 2024
$90K
7,043 services
Medicare patients, 2024
166
Average age 69
Drug cost, 2024
$1.4M
1,101 prescriptions
Company payments, 2025
$2,659
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Dariusz Chrostowski was code 95004 (test - miscellaneous), 2,782 times for 50 patients. In total Dariusz Chrostowski billed 7,043 services in 24 codes, and Medicare paid $90K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-03-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95004 Test - Miscellaneous | Office | 2,782 | 50 | $2.64 | $7,338 |
| 95165 Treatment - Miscellaneous | Office | 1,280 | 41 | $9.65 | $12K |
| 95117 Treatment - Miscellaneous | Office | 485 | 34 | $8.33 | $4,038 |
| 95024 Test - Miscellaneous | Office | 382 | 42 | $5.90 | $2,254 |
| 99213 Office E&M - Established | Office | 123 | 107 | $60.80 | $7,479 |
| 94060 Pulmonary Function Testing | Office | 42 | 37 | $27.07 | $1,137 |
| 99214 Office E&M - Established | Office | 30 | 27 | $92.81 | $2,784 |
| 99203 Office E&M - New | Office | 23 | 23 | $76.87 | $1,768 |
| 99204 Office E&M - New | Office | 20 | 20 | $116.24 | $2,325 |
By year: 2022 $50K for 5,290 services; 2023 $49K for 5,446 services; 2024 $90K for 7,043 services.
Medicare prescription drug claims, 2024
In 2024, the drug Dariusz Chrostowski prescribed most often to Medicare patients was Fluticasone Propionate, with 165 prescriptions and refills. In total Dariusz Chrostowski wrote 1,101 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Fluticasone Propionate Generic | 165 | 271 | 48 | $2,854 |
| Montelukast Sodium Generic | 163 | 286 | 30 | $1,511 |
| Azelastine Hcl Generic | 151 | 293 | 66 | $5,358 |
| Levocetirizine Dihydrochloride Generic | 103 | 203 | 22 | $1,134 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 59 | 74 | 21 | $1,814 |
| Xolair Omalizumab | 43 | 48 | Under 11 | $141K |
| Breo Ellipta Fluticasone/Vilanterol | 42 | 70 | 12 | $27K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 29 | 37 | Under 11 | $24K |
| Symbicort Budesonide/Formoterol Fumarate | 28 | 34 | Under 11 | $7,572 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 27 | 35 | Under 11 | $3,212 |
| Doxepin Hcl Generic | 26 | 46 | Under 11 | $906 |
| Epinephrine Generic | 21 | 21 | 14 | $5,179 |
| Hizentra Immun Glob G(Igg)/Pro/Iga 0-50 | 20 | 20 | Under 11 | $142K |
| Ipratropium Bromide Generic | 20 | 22 | Under 11 | $408 |
| Haegarda C1 Esterase Inhibitor | 16 | 16 | Under 11 | $719K |
Brand drugs: 288 claims; generic drugs: 813 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dariusz Chrostowski $2,659 ($2,659 in general payments such as food, travel and fees) from 17 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $590.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 18 | $590 |
| Genzyme Corporation SNY | 10 | $530 |
| GlaxoSmithKline, LLC. GSK | 15 | $417 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 8 | $303 |
| Pfizer Inc. PFE | 9 | $256 |
| Regeneron Healthcare Solutions, Inc. REGN | 6 | $165 |
| Genentech USA, Inc. ROG.SW | 3 | $73.73 |
| Amgen Inc. AMGN | 3 | $63.14 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $56.06 |
| Lilly USA, LLC LLY | 2 | $53.27 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.